Bilateral Mastectomy and Breast Cancer Mortality.
Giannakeas V, Lim DW, Narod SA.
JAMA Oncol. 2024 Sep 1;10(9):1228-1236. doi: 10.1001/jamaoncol.2024.2212.
Overall survival after mastectomy versus breast-conserving surgery with adjuvant radiotherapy for early-stage breast cancer: meta-analysis.
Rajan KK, Fairhurst K, Birkbeck B, Novintan S, Wilson R, Savović J, Holcombe C, Potter S.
BJS Open. 2024 May 8;8(3):zrae040. doi: 10.1093/bjsopen/zrae040.
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial.
Poortmans PM, Weltens C, Fortpied C, Kirkove C, Peignaux-Casasnovas K, Budach V, van der Leij F, Vonk E, Weidner N, Rivera S, van Tienhoven G, Fourquet A, Noel G, Valli M, Guckenberger M, Koiter E, Racadot S, Abdah-Bortnyak R, Van Limbergen EF, Engelen A, De Brouwer P, Struikmans H, Bartelink H; European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups.
Lancet Oncol. 2020 Dec;21(12):1602-1610. doi: 10.1016/S1470-2045(20)30472-1. Epub 2020 Nov 2.
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
Chua BH, Link EK, Kunkler IH, Whelan TJ, Westenberg AH, Gruber G, Bryant G, Ahern V, Purohit K, Graham PH, Akra M, McArdle O, O'Brien P, Harvey JA, Kirkove C, Maduro JH, Campbell ID, Delaney GP, Martin JD, Vu TTT, Muanza TM, Neal A, Olivotto IA; BIG 3–07/TROG 07.01 trial investigators.
Lancet. 2022 Aug 6;400(10350):431-440. doi: 10.1016/S0140-6736(22)01246-6.
Contouring Guidelines for the Axillary Lymph Nodes for the Delivery of Radiation Therapy in Breast Cancer: Evaluation of the RTOG Breast Cancer Atlas.
Gentile MS, Usman AA, Neuschler EI, Sathiaseelan V, Hayes JP, Small W Jr.
Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):257-65. doi: 10.1016/j.ijrobp.2015.07.002. Epub 2015 Aug 6.
Trends in Contralateral Prophylactic Mastectomy Utilization for Small Unilateral Breast Cancer.
Baskin AS, Wang T, Bredbeck BC, Sinco BR, Berlin NL, Dossett LA.
J Surg Res. 2021 Jun;262:71-84. doi: 10.1016/j.jss.2020.12.057. Epub 2021 Feb 3.
Why Are There So Many Mastectomies in the United States?
Mamtani A, Morrow M.
Annu Rev Med. 2017 Jan 14;68:229-241. doi: 10.1146/annurev-med-043015-075227. Epub 2016 Aug 26.
BRCA1/2 Mutation-associated Breast Cancer, Wide Local Excision and Radiotherapy or Unilateral Mastectomy: A Systematic Review.
Hallam S, Govindarajulu S, Huckett B, Bahl A.
Clin Oncol (R Coll Radiol). 2015 Sep;27(9):527-35. doi: 10.1016/j.clon.2015.06.001. Epub 2015 Jun 22.
Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
Hegde JV, Wang X, Attai DJ, DiNome ML, Kusske A, Hoyt AC, Hurvitz SA, Weidhaas JB, Steinberg ML, McCloskey SA.
Clin Breast Cancer. 2018 Apr;18(2):e205-e218. doi: 10.1016/j.clbc.2017.09.010. Epub 2017 Sep 27.
Patient-reported outcomes among women with unilateral breast cancer undergoing breast conservation versus single or double mastectomy.
Pesce C, Jaffe J, Kuchta K, Yao K, Sisco M.
Breast Cancer Res Treat. 2021 Jan;185(2):359-369. doi: 10.1007/s10549-020-05964-0. Epub 2020 Oct 8.
